Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Endeavor Health
With
Ann & Robert H Lurie Children's Hospital of Chicago
Northwestern University
Mead Johnson Nutrition
This will be a multi-center, randomized, placebo controlled, double blind trial.
Two doses of PUFA will be compared to placebo- a "high" dose and a "low" dose.
ELBW infants will be enrolled into this study.
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
a) Premature infant born at gestational age less than 34 weeks
b) Birth weight less than 1000 grams
c) Legally authorized representative is able to provide written informed consent within the first 72 hours of life, prior to the performance of an protocol-specified evaluations or procedures
You may not be if
a) infants with known metabolic disorder
b) infants with known congenital gastrointestinal anomaly
c) infants who are deemed to be inappropriate for enrollment per attending neonatologist
Clareo Health | PUFA Supplementation in Premature Infants
